Cargando…
Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrug-resistant Salmonella typhi have been reported as cause of resistant infections...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AboutScience
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823287/ https://www.ncbi.nlm.nih.gov/pubmed/36644017 http://dx.doi.org/10.33393/dti.2022.2532 |
_version_ | 1784866122830446592 |
---|---|
author | Sharma, Monica Walia, Kamini Bansal, Nitin |
author_facet | Sharma, Monica Walia, Kamini Bansal, Nitin |
author_sort | Sharma, Monica |
collection | PubMed |
description | Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrug-resistant Salmonella typhi have been reported as cause of resistant infections in developing countries. Here, we discuss the priority pathogens and conditions for which feasible solutions adaptable to low-resource settings are required to address the antimicrobial resistance in pathogens. These solutions will be helpful in containing the spread of antimicrobial resistance and better patient outcomes. |
format | Online Article Text |
id | pubmed-9823287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AboutScience |
record_format | MEDLINE/PubMed |
spelling | pubmed-98232872023-01-12 Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint Sharma, Monica Walia, Kamini Bansal, Nitin Drug Target Insights Short Communication Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrug-resistant Salmonella typhi have been reported as cause of resistant infections in developing countries. Here, we discuss the priority pathogens and conditions for which feasible solutions adaptable to low-resource settings are required to address the antimicrobial resistance in pathogens. These solutions will be helpful in containing the spread of antimicrobial resistance and better patient outcomes. AboutScience 2022-12-31 /pmc/articles/PMC9823287/ /pubmed/36644017 http://dx.doi.org/10.33393/dti.2022.2532 Text en Copyright © 2022, The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/© 2022 The Authors. This article is published by AboutScience and licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Commercial use is not permitted and is subject to Publisher’s permissions. Full information is available at www.aboutscience.eu (http://www.aboutscience.eu) |
spellingShingle | Short Communication Sharma, Monica Walia, Kamini Bansal, Nitin Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint |
title | Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint |
title_full | Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint |
title_fullStr | Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint |
title_full_unstemmed | Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint |
title_short | Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint |
title_sort | unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823287/ https://www.ncbi.nlm.nih.gov/pubmed/36644017 http://dx.doi.org/10.33393/dti.2022.2532 |
work_keys_str_mv | AT sharmamonica unmetneedsformanagementofdrugresistantinfectionslowandmiddleincomecountriesviewpoint AT waliakamini unmetneedsformanagementofdrugresistantinfectionslowandmiddleincomecountriesviewpoint AT bansalnitin unmetneedsformanagementofdrugresistantinfectionslowandmiddleincomecountriesviewpoint |